These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease. Farhan S; Höchtl T; Wojta J; Huber K Minerva Med; 2010 Aug; 101(4):239-53. PubMed ID: 21030936 [TBL] [Abstract][Full Text] [Related]
24. Antiplatelet therapy in type 2 diabetes mellitus. Angiolillo DJ Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430 [TBL] [Abstract][Full Text] [Related]
25. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets. Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855 [TBL] [Abstract][Full Text] [Related]
26. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD. Müller KA; Chatterjee M; Rath D; Geisler T Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127 [TBL] [Abstract][Full Text] [Related]
27. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Beckman JA; Creager MA; Libby P JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339 [TBL] [Abstract][Full Text] [Related]
28. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease. Larsen SB; Grove EL; Würtz M; Neergaard-Petersen S; Hvas AM; Kristensen SD Thromb Haemost; 2015 Aug; 114(3):519-29. PubMed ID: 26062929 [TBL] [Abstract][Full Text] [Related]
29. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients. Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875 [TBL] [Abstract][Full Text] [Related]
30. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110 [TBL] [Abstract][Full Text] [Related]
31. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422 [TBL] [Abstract][Full Text] [Related]
33. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations. Capranzano P; Capodanno D Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911 [TBL] [Abstract][Full Text] [Related]
34. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Ben-Dor I; Kleiman NS; Lev E Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352 [TBL] [Abstract][Full Text] [Related]
35. Measurement of the platelet retention rate in a column of collagen-coated beads is useful for the assessment of efficacy of antiplatelet therapy. Mende A; Obata JE; Sano K; Hirano M; Kitta Y; Kodama Y; Nakamura T; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Satoh K; Ozaki Y; Yano T; Kugiyama K Thromb Res; 2009 Apr; 123(6):856-61. PubMed ID: 19004478 [TBL] [Abstract][Full Text] [Related]
36. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Watala C Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671 [TBL] [Abstract][Full Text] [Related]
37. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439 [TBL] [Abstract][Full Text] [Related]
38. Platelet monitoring for PCI: is it really necessary? Tantry US; Gurbel PA Hamostaseologie; 2009 Nov; 29(4):368-75. PubMed ID: 19882080 [TBL] [Abstract][Full Text] [Related]
39. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty. Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225 [TBL] [Abstract][Full Text] [Related]